Physician profile
Bruno Bucci
NPI 1407811250
$33,511.21
in general payments reported to CMS, 2019-2025
54 companies · $2,404 in 2025
The $2,404 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $3,732 · 2021: $3,999 · 2022: $2,742 · 2023: $2,695 · 2024: $2,155 · 2025: $2,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,253.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15,090.58 | 2019-2025 | Evenity, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $3,201.50 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $2,036.52 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,702.04 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,381.26 | 2019-2025 | Jardiance, Tradjenta, Stiolto Respimat |
| Pfizer INC. | $919.08 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $816.09 | 2019-2023 | |
| Amarin Pharma, INC. | $784.83 | 2019-2023 | |
| Abbvie INC. | $693.71 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Janssen Pharmaceuticals, INC | $672.32 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $654.72 | 2021-2025 | |
| Glaxosmithkline, LLC. | $621.68 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $498.16 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $392.97 | 2020-2023 | Cuvitru, Hyqvia |
| Mannkind Corporation | $356.31 | 2019-2025 | Afrezza |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $355.84 | 2019-2021 | |
| Corcept Therapeutics | $278.56 | 2025 | Korlym |
| Kowa Pharmaceuticals America, INC. | $259.90 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $238.07 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $219.43 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Allergan, INC. | $219.32 | 2019-2020 | |
| Radius Health, INC. | $213.74 | 2019-2023 | Tymlos |
| Xeris Pharmaceuticals, INC. | $206.64 | 2022-2025 | Gvoke Hypopen |
| Dexcom, INC. | $192.38 | 2021-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $164.28 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $149.46 | 2021-2025 | Freestyle Libre 3 |
| Medtronic Minimed, INC. | $129.57 | 2020 | |
| Philips North America LLC | $112.59 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $108.05 | 2023 | Tecnis Simplicity |
| Insulet Corporation | $86.77 | 2025 | Omnipod |
| Zyla Life Sciences, INC. | $72.34 | 2019 | |
| Medtronic, INC. | $49.42 | 2021-2022 | |
| Horizon Therapeutics Plc | $47.50 | 2019-2023 | Krystexxa |
| Otsuka America Pharmaceutical, INC. | $45.11 | 2021-2023 | Rexulti |
| Medtronic Vascular, INC. | $42.97 | 2019-2020 | |
| Genentech USA, INC. | $41.66 | 2020 | |
| Phathom Pharmaceuticals, INC. | $39.79 | 2024-2025 | Voquezna |
| Biohaven Pharmaceuticals, INC. | $38.37 | 2021 | |
| Inspire Medical Systems, INC. | $36.35 | 2024 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $35.35 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $35.06 | 2020 | |
| Biogen, INC. | $34.24 | 2020-2025 | Leqembi |
| Lundbeck LLC | $34.10 | 2023 | Rexulti |
| Cequr Corporation | $26.79 | 2022-2024 | Cequr Simplicity |
| Teva Pharmaceuticals USA, INC. | $25.01 | 2019 | |
| Sun Pharmaceutical Industries INC. | $24.64 | 2020 | |
| Eisai INC. | $21.44 | 2021 | |
| Echosens North America, INC. | $21.05 | 2025 | Fibroscan |
| Azurity Pharmaceuticals, INC. | $20.60 | 2023 | Horizant |
| Cranial Technologies, INC | $14.94 | 2019 | |
| Esperion Therapeutics, INC. | $13.54 | 2020 | |
| Sanofi Pasteur INC. | $13.54 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.40 | 2019 | |
| Endogastric Solutions, INC | $9.63 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruno Bucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.